Filter
6534
Filtered Results: 6534
Text search:
Ministry
of
Health
and
Population
Featured
Recommendations
428
New Publications
2153
Language
Document type
No document type
4117
Studies & Reports
1044
Guidelines
579
Manuals
259
Strategic & Response Plan
242
Situation Updates
92
Training Material
86
Fact sheets
82
Resource Platforms
14
Infographics
13
Brochures
4
App
1
Online Courses
1
Countries / Regions
India
349
Kenya
270
Nepal
260
Ethiopia
197
Global
193
Uganda
183
Sierra Leone
168
Myanmar / Burma
158
Nigeria
152
Rwanda
152
Liberia
145
Malawi
132
Zambia
131
Bangladesh
121
Tanzania
113
Congo, Democratic Republic of
111
Syria
95
Western and Central Europe
95
Ghana
87
Ukraine
86
Namibia
81
Africa
75
Latin America and the Carribbean
74
Senegal
73
Lesotho
69
South Sudan
68
Cambodia
67
Haiti
66
Zimbabwe
59
Burkina Faso
49
Indonesia
49
Mozambique
49
Guinea
47
Eastern Europe
47
Cameroon
46
South Africa
44
Benin
41
Asia
41
Botswana
40
South–East Asia Region
38
Yemen
36
Brazil
35
Venezuela
30
Madagascar
28
Eswatini/ Swaziland
26
East and Southern Africa
26
West and Central Africa
25
Pakistan
23
Afghanistan
21
Central African Republic
21
Jordan
20
Lebanon
19
Colombia
19
Mali
18
Philippines
17
Middle East and North Africa
17
Somalia
16
Germany
16
Tajikistan
16
Russia
16
Iraq
15
Eastern Europe and Central Asia
15
Vietnam
15
Thailand
14
Sudan
14
Peru
13
Albania
13
Côte d’Ivoire / Ivory Coast
12
Togo
12
Moldova
12
Sri Lanka
11
Paraguay
11
Laos
11
Turkey
10
Western Pacific Region
10
Niger
9
China
9
Chile
9
Georgia
8
Burundi
7
Ecuador
7
Angola
7
Palestine
7
North Macedonia
6
El Salvador
6
Greece
6
Kyrgyzstan
6
Chad
5
Argentina
5
Bolivia
5
Libya
5
Poland
5
Armenia
5
Timor Leste/ East Timor
5
Iran
5
Guinea-Bissau
4
Egypt
4
Hungary
4
Mexico
4
Canada
4
Romania
4
North America
4
Turkmenistan
4
Morocco
3
Saudi Arabia
3
Gambia
3
Malaysia
3
Singapore
3
Papua New Guinea
3
Serbia
3
Croatia
3
Bhutan
3
Southern Africa
3
Kazakhstan
3
Jamaica
3
France
3
Mauritius
3
Bosnia and Herzegovina
3
Vanuatu
2
Honduras
2
Italy
2
Congo-Brazzaville
2
Bulgaria
2
Lithuania
2
Slovakia
2
Japan
2
Portugal
2
Spain
2
Azerbaijan
2
Belarus
2
Israel
2
USA
1
Dominican Republic
1
Guatemala
1
Nicaragua
1
Fiji
1
Solomon Islands
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Estonia
1
Uzbekistan
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3408
Clinical Guidelines
324
Public Health
309
Women & Child Health
265
Key Resources
236
Capacity Building
86
Pharmacy & Technologies
32
Annual Report MEDBOX
3
Protection & Security
2
General Guidelines
1
Toolboxes
HIV
441
COVID-19
424
Mental Health
329
TB
299
Disability
229
Conflict
212
Ebola
201
Rapid Response
187
Planetary Health
176
AMR
136
Caregiver
126
NTDs
112
Refugee
108
Natural Hazards
97
Pharmacy
91
Global Health Education
80
NCDs
75
Cholera
47
Health Financing Toolbox
47
Zika
36
Polio
27
Specific Hazards
21
Social Ethics
13
Typhoon
7
South Sudan
2
Health Financing
2
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case ...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within ... between countries, whether and when to mandate vaccines and/or masks, whether and how to conduct public health surveillance, whether to issue vaccine passports, and how to address stark international and intranational inequities. In addition, there have been ethical concerns about the conduct of COVID-19 research, such as the appropriateness of challenge studies.
Guidance
Second Edition
Monitoring and Evaluation
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strateg...
Ukrainian decentralization reform has increased and democratized local government responsibility for health care at the level of local government c...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility ... measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by high disease burden in some countries, as well as delays in reaching mortality targets due to the long natural history of disease progression to liver cirrhosis and hepatocellular carcinoma.
The path to elimination provides a framework with 3 levels of achievements for which WHO certification is available. Each stepwise progression from bronze to silver to gold tiers will promote an iterative expansion of prevention, diagnosis and treatment services for viral hepatitis services and strengthen measurement systems to support attainment of the 2030 elimination goals.
This updated version also includes changes, clarifications and new guidance on alternative measurement approaches for country validation of elimination. Through the validation process, WHO and partners continue to provide country support for strengthening health system capacity and patient-centred services that respect and protect the human rights of people living with viral hepatitis and ensures meaningful engagement of communities in the national, regional and global viral hepatitis response.
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating ... preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance inclu...
This manual describes methods for investigating clusters or outbreaks that may be of chemical origin and describes the importance of a structured, ...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create t...
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that ... a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2025. The main focus of this action plan is on 4 types of NCDs (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes) which make the largest contribution to morbidity and mortality due to NCDs, and on 4 shared behavioural risk factors (tobacco use, unhealthy diet, physical inactivity, harmful use of alcohol).
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental ..., cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).
